 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | RG4929 / Roche
Trial completion, Enrollment change: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). (clinicaltrials.gov) - Mar 21, 2017
P1, N=45, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Completed | N=60 --> 45
- || RG4929 / Roche, RG7234 / Roche
Trial primary completion date: A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin (clinicaltrials.gov) - Jul 28, 2016
P2, N=110, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Completed | N=60 --> 45 Trial primary completion date: Mar 2010 --> Aug 2009
- ||| RG4929 / Roche
New P1 trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). (clinicaltrials.gov) - Dec 5, 2015
P1, N=60, Recruiting, Sponsor: Hoffmann-La Roche
- | RG4929 / Roche
Trial completion: A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma (clinicaltrials.gov) - May 22, 2013
P2, N=31, Completed, Sponsor: Hoffmann-La Roche
Trial primary completion date: Mar 2010 --> Aug 2009 Active, not recruiting --> Completed
- | RG4929 / Roche
Enrollment change: A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma (clinicaltrials.gov) - Jan 2, 2013
P2, N=31, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed N=60 --> 31
- ||| RG4929 / Roche
New P1 trial: A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers (clinicaltrials.gov) - May 2, 2012
P1, N=51, Completed, Sponsor: Hoffmann-La Roche
- ||| RG4929 / Roche
Trial completion: A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease (clinicaltrials.gov) - Apr 17, 2012
P1, N=82, Completed, Sponsor: Hoffmann-La Roche
N=60 --> 31 Active, not recruiting --> Completed
- | RG4929 / Roche
New P2 trial: A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma (clinicaltrials.gov) - Dec 13, 2011
P2, N=31, Completed, Sponsor: Hoffmann-La Roche